We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

SYGNIS Signs Non-Exclusive Distribution Agreement with SOPACHEM

News   Mar 19, 2015

 
SYGNIS Signs Non-Exclusive Distribution Agreement with SOPACHEM
 
 
 

RELATED ARTICLES

Putting Concussion Under the Genetic Microscope

News

The world’s first study on whether genetic variations are involved in the post-traumatic headache experienced by some people following concussion is underway at QUT, funded by a $250,000 US Department of Defence grant.

READ MORE

Diagnosing Lung Cancer With Artificial Intelligence

News

A new study reports that deep learning — a form of artificial intelligence — was able to detect malignant lung nodules on low-dose chest computed tomography scans with a performance meeting or exceeding that of expert radiologists.

READ MORE

Single-cell Analysis Opens Doors for Targeted Treatment in Autism Spectrum Disorder

News

Researchers have adopted single-cell analysis to uncover the molecular underpinnings of Autism Spectrum Disorder (ASD). Their findings may have implications for targeted therapeutics.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE